News | Proton Therapy | November 20, 2015

Mevion to Install Three-Room Proton Therapy System in Los Angeles

Installation will be done in phases, with first room opening for treatments in late 2017

Mevion S250mx, Los Angeles Proton Center, three-room proton therapy system

Image courtesy of Mevion Medical Systems

November 20, 2015 – Mevion Medical Systems is announcing the Los Angeles Proton Center is building a three-room Mevion S250mx proton therapy system. The system will include Mevion’s Hyperscan pencil beam scanning technology and will be installed near Los Angeles, in the city of Montebello, on the campus of Beverly Hospital. The installation will take place in phases, with the first of the three rooms treating cancer patients in late 2017.

“The Mevion S250mx was the optimal solution for our facility because it allows for a flexible, phased installation,” said Charles Liu, president of the Los Angeles Proton Center. “Just as importantly, we continue to be impressed with the proven results of all of Mevion’s clinically operational systems, including Mevion’s industry-leading ramp-up time, high patient throughput, and low staffing and maintenance requirements. The decision to select Mevion and its product solutions will allow us to consistently provide high-quality proton therapy to a large number of patients.”

The Mevion S250mx is the fully scalable version of Mevion’s proton therapy technology and is available in two-, three- or four-room configurations. Each room is fully independent, with its own proton accelerator, providing inherent redundancy and 100 percent facility uptime 365 days per year. 

The Los Angeles Proton Center is an independent proton center that will collaborate with renowned cancer specialists to treat adult and pediatric cancer patients from the Greater Los Angeles area. The center will also serve international patients who are seeking cancer care on the West Coast of the United States.

Similar Mevion systems have ramped up to full capacity in as little as three months and achieved an annualized rate of 350 patients per room, per year. That is more than 25 percent better than the average U.S. proton therapy center. 

The Los Angeles system is the third system purchase announced by Mevion in the past six weeks. In October, Mevion announced the installation of a Mevion S250 to Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne, Switzerland, and a Mevion S250i with Hyperscan to the Ackerman Cancer Center in Jacksonville, Florida.

Hyperscan has not been cleared by the U.S. Food and Drug Administration for clinical use.

For more information: www.mevion.com

Related Content

Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.